Key result
Chronic diabetic hyperglycaemia improved systolic function and reduced myocardial infarction size by 36% in rats 15 days post-MI, accompanied by increased angiogenesis and reduced fibrosis.
Why the study?
Does chronic diabetic hyperglycemia protect the heart against ischemic injury after myocardial infarction in a rat model?
Does chronic diabetic hyperglycemia protect the heart against ischemic injury after myocardial infarction in a rat model?
In a rat model, chronic diabetic hyperglycemia appears to confer cellular resistance to ischemic injury and greater plasticity post-myocardial infarction.
Answers are grounded in this paper and cite their sources.
Hyperglycaemia may protect diabetic rat hearts post-MI; leaves open human translation.
AIMS: Exposure to a high glucose medium or diabetes has been found to protect the heart against ischaemia. The activation of antiapoptotic and proliferative factors seems to be involved in this cardioprotection. This study was designed to evaluate the role of hyperglycaemia in cardiac function, programmed cell survival, and cell death in diabetic rats after myocardial infarction (MI). METHODS AND RESULTS: Male Wistar rats were divided into four groups (n = 8): control (C), diabetic (D), myocardial infarcted (MI), and diabetic myocardial infarcted (DI). The following measures were assessed in the left ventricle: size of MI, systolic and diastolic function by echocardiography, cytokines by ELISA (TNF-alpha, IL-1beta, IL-6, and IL-10), gene expression by real-time PCR (Bax, Fas, p53, Bcl-2, HIF1-alpha, VEGF, and IL8r), caspase-3 activity by spectrofluorometric assay, glucose transporter type 1 and 4 (GLUT-1 and GLUT-4) protein expression by western blotting, and capillary density and fibrosis by histological analysis. Systolic function was improved by hyperglycaemia in the DI group, and this was accompanied by no improvement in diastolic dysfunction, a reduction of 36% in MI size, reduced proinflammatory cytokines, apoptosis activation, and an increase in cell survival factors (HIF1-alpha, VEGFa and IL8r) assessed 15 days post-MI. Moreover, hyperglycaemia resulted in angiogenesis (increased capillary density) before and after MI, accompanied by a reduction in fibrosis. CONCLUSION: Together, these results suggest that greater plasticity and cellular resistance to ischaemic injury result from chronic diabetic hyperglycaemia in rat hearts.
No takes yet. Share an insight, caveat, or question.
Malfitano et al. (2010) studied Myocardial infarction (n=32). Hyperglycaemia (diabetes) vs. Normoglycaemia (non-diabetic) was evaluated on Myocardial infarction size (36% reduction). Chronic diabetic hyperglycaemia improved systolic function and reduced myocardial infarction size by 36% in rats 15 days post-MI, accompanied by increased angiogenesis and reduced fibrosis.
Synapse has enriched 10 related papers. Consider them for comparative context: